Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Anixa Biosciences Inc (ANIX)

Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 ACCESS Newswire - Fri Dec 6, 2024

RALEIGH, NC / ACCESSWIRE / December 6, 2024 / iAccess Alpha's "Buyside Best Ideas Virtual Winter Conference" is taking place on December 10-11, 2024.

IPWR : 5.01 (+2.35%)
HPAI : 5.76 (+6.08%)
PRE : 4.30 (+1.42%)
ANIX : 3.10 (-1.27%)
INUV : 0.4280 (-1.22%)
BNZI : 1.0800 (-9.24%)
DHX : 1.6850 (-2.60%)
AZ : 7.22 (-1.84%)
NXGL : 2.76 (-0.93%)
NTWK : 2.42 (+1.26%)
CDZI : 3.48 (+1.16%)
Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology PR Newswire - Tue Oct 3, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)
Anixa Biosciences Establishes Cancer Business Advisory Board PR Newswire - Tue Sep 19, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)
Jobs Numbers Roll out in Canada During Shortened Week Baystreet - Fri Sep 1, 2023

Monday Markets are closed for Labour Day Tuesday U.S. Economic Lookahead ...

ZS : 202.97 (-0.48%)
GTLB : 50.66 (-1.82%)
HQY : 82.88 (-1.71%)
CPRT : 53.82 (-0.11%)
PATH : 10.84 (+0.37%)
CNM : 48.64 (-0.84%)
TTS : 1.46 (-11.52%)
DOCU : 84.94 (-0.78%)
SAIC : 105.94 (-6.06%)
KR : 64.63 (-1.30%)
ANIX : 3.10 (-1.27%)
RENT : 6.24 (+29.19%)
Anixa Biosciences to Participate in September Investor Conferences PR Newswire - Thu Aug 31, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)
Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial PR Newswire - Mon Aug 28, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)
Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)
Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial PR Newswire - Mon Aug 7, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

MRK : 94.24 (+0.23%)
ANIX : 3.10 (-1.27%)
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology PR Newswire - Thu Jul 27, 2023

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 3.10 (-1.27%)

Barchart Exclusives

How High Can This Growth Stock Go After Doubling in 2025? Barchart - Thu Mar 20, 9:30AM CDT
Xpeng Motors stock has nearly doubled in 2025 on the back of the company’s impressive deliveries and progress in AI. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot